| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.23 | 6e-06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.5 | 0.0009 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.15 | 0.002 |